Diabetes insipidus and SIADH: Pathology review

12,890views

test

00:00 / 00:00

Diabetes insipidus and SIADH: Pathology review

URR1

URR1

Fick's laws of diffusion
Diffusion-limited and perfusion-limited gas exchange
Carbon dioxide transport in blood
Oxygen-hemoglobin dissociation curve
Gas exchange in the lungs, blood and tissues
Oxygen binding capacity and oxygen content
Ventilation-perfusion ratios and V/Q mismatch
Measuring cardiac output (Fick principle)
Electron transport chain and oxidative phosphorylation
Regulation of pulmonary blood flow
Pulmonary edema
Pulmonary shunts
Physiologic pH and buffers
Buffering and Henderson-Hasselbalch equation
Pulmonary chemoreceptors and mechanoreceptors
Anatomy of the pterygopalatine (sphenopalatine) fossa
Anatomy of the nose and paranasal sinuses
Anatomy clinical correlates: Temporal regions, oral cavity and nose
Anatomy of the pharynx and esophagus
Zones of pulmonary blood flow
Ventilation
Airflow, pressure, and resistance
Pulmonary changes at high altitude and altitude sickness
Anatomy of the tongue
Diffuse parenchymal lung disease: Clinical
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Ureter, bladder and urethra histology
Kidney histology
Nephrotic syndromes: Pathology review
Renal clearance
Glomerular filtration
TF/Px ratio and TF/Pinulin
Measuring renal plasma flow and renal blood flow
Regulation of renal blood flow
Diabetes insipidus and SIADH: Pathology review
The role of the kidney in acid-base balance
Loop diuretics
Carbonic anhydrase inhibitors
Acid-base map and compensatory mechanisms
Strong acid-strong base titration
Tubular reabsorption and secretion of weak acids and bases
Intestinal fluid balance
Renal tubular acidosis
Metabolic acidosis
Respiratory acidosis
Renal tubular acidosis: Pathology review
Hypokalemia
Metabolic and respiratory acidosis: Clinical
Electrolyte disturbances: Pathology review
Making buffer solutions
Acid-base disturbances: Pathology review
Urinary incontinence: Pathology review
Hyperaldosteronism
Metabolic and respiratory alkalosis: Clinical
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hyponatremia: Clinical
Antidiuretic hormone
Osmoregulation
Diabetes insipidus
Thiazide and thiazide-like diuretics
Urea recycling
Vesicoureteral reflux

Evaluaciones

USMLE® Step 1 questions

0 / 5 complete

Preguntas

Preguntas del estilo USMLE® Step 1

0 de 5 completadas

A 30 year-old woman comes to her primary care physician because of muscle cramps, nausea, and fatigue. The patient endorses a history of depression and seizure disorder, both of which are currently managed with medications. Family history is notable for Addison disease in her maternal uncle. Temperature is 36.9°C (98.4°F), pulse is 75/min, respirations are 14/min and blood pressure is 115/80 mmHg. Cardiac, pulmonary, and abdominal examinations are noncontributory. Additional laboratory results are as follows:  
 
Laboratory value  Result 
Sodium   122 mEq/L 
 Potassium   3.7 mEq/L 
 Creatinine  0.9 mg/dL 
 Glucose  102 mg/dL 
 Serum osmolality   240 mOsm/kg 
 Urine osmolality  445 mOsm/kg 

Which of the following is the most likely explanation of the patient’s symptoms?

Transcripción

Ver video solo

Okay, so two people were admitted to the Endocrinology ward. One of them is 35 year old Imre, who came in with intense polyuria and polydipsia. Imre was dehydrated and presented with dry mouth, headache, dry skin and dizziness. Several tests were done and results showed increased serum osmolality and further on, a desmopressin test was done. During the test, an ADH analogue was administered and urine osmolality increased. The other person is 45 year old Sienna who came in to do some routine tests because she started taking cyclophosphamide and wanted to make sure that there are no complications. Her lab results showed hyponatremia, decreased blood osmolality, and her urine osmolality was higher than serum osmolality.

Now, both individuals are unable to maintain normal osmolality. But to understand this we need to go over a bit of physiology first. In the brain, specifically in the hypothalamus, there are osmoreceptors which can sense the osmolality of the blood, or how concentrated it is. Osmolality is the concentration of dissolved particles in the blood plasma, or the liquid portion of blood. There are a number of dissolved particles in the blood plasma, but the major ones are glucose, sodium, and blood urea nitrogen, and a normal osmolality is between 285 and 295 milliOsmoles per kilogram.

Now, during periods of dehydration there is an increase in concentration of these particles in the blood and osmolality increases. The osmoreceptors in the hypothalamus sense the change in osmolality and this triggers the sensation of thirst. The water that we drink gets absorbed and dilutes the blood, bringing the osmolality back to normal.

In addition to osmoreceptors, the hypothalamus also contains the supraoptic and paraventricular nuclei that produce antidiuretic hormone, or ADH, which is then sent to the posterior pituitary for storage. ADH is also called vasopressin because it causes smooth muscle around the blood vessels to contract, which increases resistance and raises blood pressure.

When the osmoreceptors detect high osmolality, they signal the supraoptic nucleus to send ADH into the blood which travels to the kidneys, specifically to the principal cells in the distal convoluted tubule, and collecting ducts, of the nephrons. Here ADH binds to a receptor called vasopressin receptor 2, or VR2. This causes aquaporin proteins inside the principal cells to embed into the cell membrane and open a channel that only lets water from the lumen of the nephron back into the blood. Just like drinking more water, this dilutes the blood, and returns plasma osmolality to a normal level. However, this reabsorption process also decides how much water leaves the body as urine, and how concentrated the urine is, which is one of the things that keeps a normal urine osmolality between 300 and 900 milliOsmoles per kilogram.

Now that we know all this, diabetes insipidus is when the kidneys reabsorb too little water, so the water remains in the nephrons and is lost via urine. This leads to a lot of dilute urine, or polyuria. Since there’s less water in the blood, plasma osmolality increases and that triggers thirst and polydipsia. Now, if the problem is caused by a lack of ADH, it’s called central diabetes insipidus. If it’s due to a decreased response to ADH by the kidneys, it’s called nephrogenic diabetes.

Let’s start with central diabetes insipidus, which can be caused by conditions that affect the hypothalamus, in which case it won’t be able to produce ADH, or conditions that affect the pituitary gland, in which case there’s no place to store the ADH, and in some cases, both the hypothalamus and the pituitary gland are affected. As a result, there’s insufficient ADH in the blood, and that means there is less vasoconstriction, and insufficient aquaporins in the distal convoluted tubule and collecting duct. Some causes of central diabetes insipidus include pituitary tumors, head trauma, head surgery, ischemic encephalopathy, autoimmune conditions or sometimes, the cause can be idiopathic.

Then there’s nephrogenic diabetes insipidus, which is when there’s a problem with the kidneys themselves, which makes them unresponsive to ADH. A high yield fact is that this is often due to a hereditary genetic defect of the vasopressin receptors or aquaporin proteins. Both of these lead to nephrons that are unresponsive to ADH. In addition, there are medications like lithium that can decrease the production of aquaporin proteins in the collecting duct. Sometimes, nephrogenic diabetes insipidus can be caused by hypokalemia. That’s because the aquaporins can degrade in the early phases of hypokalemia. Sometimes nephrogenic diabetes can also be secondary to hypercalcemia, through an unclear mechanism. Finally, demeclocycline, which is an ADH antagonist, can block the vasopressin receptors, leading to nephrogenic diabetes insipidus.

Now, the symptoms of both central and nephrogenic diabetes insipidus are polyuria and polydipsia and you have to remember this for your tests. A person with diabetes insipidus typically produces over 3 liters of dilute urine each day, so it can quickly lead to dehydration and hypotension. The increase in plasma osmolality can result in fatigue, nausea, poor concentration, or confusion.

The diagnosis of diabetes insipidus starts with a blood osmolality test, which would show an increased blood osmolality of above 290 milliosmoles per kilogram in both central and nephrogenic diabetes insipidus. The urine specific gravity is lower than 1006, meaning the kidneys aren’t able to properly concentrate urine. There’s also hyperosmotic volume contraction This means that there’s decreased extracellular fluid in the body, and the remaining fluid is hyperosmotic since the water is lost, but the solutes remain. Okay, the way to differentiate central and nephrogenic diabetes insipidus is to look at the ADH level; with central diabetes insipidus, there’s low ADH, while with nephrogenic diabetes insipidus, ADH is normal or high. Remember this as it’s a very high yield concept.

In addition, a water deprivation test can be done to distinguish diabetes insipidus from psychogenic polydipsia, which is when an individual drinks more water than they need, because of a variety of psychological or psychiatric causes. That’s where an individual doesn’t drink water for 2 to 3 hours, then hourly measurements of urine volume and osmolality are done. In a person with diabetes insipidus, urine osmolality will normally stay below 300 mOsm/kg despite having no fluid intake. With psychogenic polydipsia, urine osmolality increases during the test.

Fuentes

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "undefined" Reviews in Endocrine and Metabolic Disorders (2003)
  4. "Treatment of Lithium-Induced Diabetes Insipidus with Amiloride" Pharmacotherapy (2003)
  5. "Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment" Mayo Clinic Proceedings (2010)
  6. "Syndrome of Inappropriate Antidiuretic Hormone Secretion Induced by a Single Dose of Oral Cyclophosphamide" Annals of Pharmacotherapy (2012)